United States

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

22 Jul 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Tue, Jun 7 2016

BRIEF-Oxford BioMedica grants to MolMed non-exclusive licence under its LentiVector platform technology

* Signs with Oxford BioMedica new non-exclusive licence agreement concerning lentiviral vector technology

BRIEF-Oxford Biomedica says Chief Development Officer Blake to leave in Aug

* Announces that Dr Paul Blake will leave group when his current contract expires at end of August 2016.

BRIEF-Oxford Biomedica presents lentivector gene therapy data

* Presents ground-breaking evidence of long-term duration of therapeutic expression in patients from lentivector gene delivery platform Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

BRIEF-Oxford Biomedica FY gross income up 28 pct

* Oxford biomedica: preliminary results for year ended 31 December 2015

BRIEF-Oxford Biomedica expands deal with Immune Design

* Oxford Biomedica announces expanded collaboration and licence with Immune Design

Select another date: